Ajulemic Acid (IP-751): Synthesis, Proof of Principle, Toxicity Studies, and Clinical Trials

doi 10.1007/978-0-387-76678-2_40
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer New York

Related search

First Proof-Of-Principle of Inorganic Perovskites Clinical Radiotherapy Dosimeters

APL Materials
Materials ScienceEngineering
2019English

Transmitochondrial Mice: Proof of Principle and Promises

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2001English

Clinical Pathology Testing in Toxicity Studies

Toxicologic Pathology
Forensic MedicineToxicologyPathologyCell BiologyMolecular Biology
1992English

Combination Chemotherapy of Schistosomiasis in Laboratory Studies and Clinical Trials

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2003English

Investigation of Drug Interactions by Clinical Studies^|^frasl;Trials

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
2013English

Extrapolation of Oligonucleotide Dose Levels Used in Nonclinical Toxicity Studies to Selection of Safe Starting Dose Levels in Human Clinical Trials

Nucleic Acid Therapeutics
BiochemistryMolecular MedicineDrug DiscoveryGeneticsMolecular Biology
2019English

Further Studies on Clinical Trials of Interferon in Japan

Japanese Journal of Medical Science and Biology
1984English

Proof of Principle: The Adaptive Geometry of Social Foragers

Animal Behaviour
EvolutionEcologySystematicsAnimal ScienceBehaviorZoology
2016English

Trials and Tribulations: Thoughts on the Organisation of Multicentre Clinical Studies.

BMJ
1980English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy